» Articles » PMID: 37627758

Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review

Abstract

Most antimicrobial drugs need an intravenous (IV) administration to achieve maximum efficacy against target pathogens. IV administration is related to complications, such as tissue infiltration and thrombo-phlebitis. This systematic review aims to provide practical recommendations about diluent, pH, osmolarity, dosage, infusion rate, vesicant properties, and phlebitis rate of the most commonly used antimicrobial drugs evaluated in randomized controlled studies (RCT) till 31 March 2023. The authors searched for available IV antimicrobial drugs in RCT in PUBMED EMBASE, EBSCO CINAHL and the Cochrane Controlled Clinical trials. Drugs' chemical features were searched online, in drug data sheets, and in scientific papers, establishing that the drugs with a pH of <5 or >9, osmolarity >600 mOsm/L, high incidence of phlebitis reported in the literature, and vesicant drugs need the adoption of utmost caution during administration. We evaluated 931 papers; 232 studies were included. A total of 82 antimicrobials were identified. Regarding antibiotics, 37 reach the "caution" criterion, as well as seven antivirals, 10 antifungals, and three antiprotozoals. In this subgroup of antimicrobials, the correct vascular access device (VAD) selection is essential to avoid complications due to the administration through a peripheral vein. Knowing the physicochemical characteristics of antimicrobials is crucial to improve the patient's safety significantly, thus avoiding administration errors and local side effects.

Citing Articles

Medication Safety in Intravenous Therapy: Compatibility of Etoposide with Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration.

Ding H, Tong T, Liu S, Tang L, Chen Z Drug Des Devel Ther. 2025; 19:1147-1161.

PMID: 39991084 PMC: 11846525. DOI: 10.2147/DDDT.S489534.


Correlation Between the Use of Vesicant Medications and The Incidence of Phlebitis in Pediatric Ward.

Annisa L, Hanifah S, Setiani P J Pharm Bioallied Sci. 2025; 16(Suppl 4):S4103-S4106.

PMID: 39926814 PMC: 11805223. DOI: 10.4103/jpbs.jpbs_1062_24.


Vascular Access Device Infections: Current Management Practices and the Role of Multidisciplinary Teams at a Large Hospital in Northern Italy.

Colaneri M, Galli L, Offer M, Borgonovo F, Scaglione G, Genovese C Antibiotics (Basel). 2025; 14(1).

PMID: 39858313 PMC: 11763287. DOI: 10.3390/antibiotics14010027.


Analysis of the Integrated Management Model of Medical Care and Medication in Intravenous Treatment for Critically Ill Patients.

Gao P, Wu Y, Wu X, Bai J, Shen K, Yin Y J Multidiscip Healthc. 2024; 17:4793-4801.

PMID: 39434827 PMC: 11492917. DOI: 10.2147/JMDH.S478218.


Optimizing Infusate Flow Patterns for Minimizing Vein Wall Trauma: An Exploratory Study with a Modified off-Axis Catheter Tip Opening.

Bahl A, Gibson S, Walton A Ther Clin Risk Manag. 2024; 20:559-566.

PMID: 39247171 PMC: 11380876. DOI: 10.2147/TCRM.S479846.


References
1.
van Duijnhoven W, van Dromme I, Haesendonckx S, Witek J, Leopold L . The Hospital Recovery Scale: A clinically useful endpoint in patients hospitalized with influenza. Contemp Clin Trials. 2022; 123:106952. DOI: 10.1016/j.cct.2022.106952. View

2.
Roach M, Figueroa T, McBride D, George W, Neal Jr D . Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy. Urology. 1991; 38(1):84-7. DOI: 10.1016/0090-4295(91)80024-2. View

3.
Shepp D, Dandliker P, Meyers J . Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. N Engl J Med. 1986; 314(4):208-12. DOI: 10.1056/NEJM198601233140404. View

4.
Liesveld J, Abboud C, Ifthikharuddin J, Lancet J, Wedow L, Oliva J . Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients. Biol Blood Marrow Transplant. 2003; 8(12):662-5. DOI: 10.1053/bbmt.2002.v8.abbmt080662. View

5.
Gupta A, Swaroop C, Agarwala S, Pandey R, Bakhshi S . Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. J Pediatr Hematol Oncol. 2009; 31(9):635-41. DOI: 10.1097/MPH.0b013e3181acd8cd. View